查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1598480

毒理學測試外包市場：按方法、業務類型、最終用途分類 – 2025-2030 年全球預測

Toxicity Testing Outsourcing Market by Method (In-Vitro toxicity testing, In-Vivo toxicity testing), Practice Type (Good Laboratory Practices (GLP), Non-GLP), End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年毒理學測試外包市場規模為39.7億美元，預計2024年將達到43.1億美元，複合年成長率為9.03%，預計到2030年將達到72.8億美元。

毒理學測試外包的範圍涉及與外部實驗室和服務供應商簽訂契約，進行測試以評估化學品、藥物和其他物質的安全性和潛在有害影響。由於公司需要遵守嚴格的監管要求、控制成本並利用內部不具備的專業知識，因此必須採用這種方法。最終用途包括製藥、化妝品、食品和飲料以及製藥、農業化學品、生物技術和消費品等行業的環境分析。市場成長的推動因素包括研發費用的增加、測試方法的技術進步以及對化學品安全和環境影響意識的增強。此外，向非動物測試的轉變以及對毒性預測和高通量篩檢的重視正在為創新和持續研究開闢新的途徑。新興市場的擴張和日益嚴格的法律規範也推動了對專業服務的需求。

主要市場統計
基準年[2023] 39.7億美元
預測年份 [2024] 43.1億美元
預測年份 [2030] 72.8億美元
複合年成長率（%） 9.03%

然而，一些挑戰阻礙了市場的擴張。其中包括監管障礙、對動物測試的道德擔憂以及先進測試技術的高成本。此外，不同地區的不同法規可能會使全球企業發展變得複雜，並且需要測試能夠適應不同司法管轄區並合規的解決方案。儘管存在這些挑戰，投資於技術主導的創新，例如將人工智慧和機器學習整合到毒性預測模型中以及擴大夥伴關係和協作，可以推動市場成長。

公司應優先考慮並利用體外、電腦和替代測試方法、能源和成本效益高的流程以及生物技術在毒性預測中的應用的創新發展。市場是動態的，並隨著技術進步和監管環境的變化而發展，突顯出需要持續監控和適應，以跟上新趨勢和法律變化。參與研究聯盟進一步促進知識共用，加速整個網路產業標準的進步，並確保持續的業務成長。

市場動態：揭示快速發展的毒理學測試外包市場的關鍵市場洞察

毒理學測試外包市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 動物實驗的倫理問題日益嚴重
    • 對藥物發現和個人化醫療的日益關注
    • 增加毒性資料庫
  • 市場限制因素
    • 缺乏確定體內條件複雜性的標準
  • 市場機會
    • 由於 3D 細胞培養系統的發展，毒性測試服務的接受範圍擴大
    • 由於節省時間的安全參數，毒性測定被廣泛採用
  • 市場挑戰
    • 缺乏經過毒性測試程序訓練的專家

波特五力：駕馭毒理學測試外包市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解毒理學測試外包市場的外部影響

外部宏觀環境因素在塑造毒理學測試外包市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解毒理學測試外包市場的競爭格局

對毒理學測試外包市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣毒性測試外包市場供應商績效評估

FPNV 定位矩陣是評估毒理學測試外包市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了毒理學測試外包市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，毒理學測試外包市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 動物實驗的倫理問題日益嚴重
      • 對藥物發現和個人化醫療的日益關注
      • 增加毒性資料庫
    • 抑制因素
      • 缺乏建立體內複雜情況的標準
    • 機會
      • 3D 細胞培養系統的進步提高了毒性測試服務的接受度
      • 由於安全且省時的參數，毒性測試被廣泛採用
    • 任務
      • 缺乏經過訓練的毒性測試程序專業知識
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章毒理學測試外包市場：依方法

  • 試管內毒性試驗
  • 體內毒性試驗

第7章依治療類型分類的毒理學測試外包市場

  • 良好實驗室規範 (GLP)
  • 非GLP

第8章毒理學測試外包市場：依最終用途分類

  • 學術研究所
  • 製藥和生物製藥公司

第9章 北美、南美毒理學檢測外包市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太毒理學檢測外包市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲毒理學檢測外包市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biognosys AG
  • BioIVT, LLC
  • Catalent, Inc.
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • Eagle Analytical
  • Eurofins Scientific Limited
  • Evotec SE
  • Laboratory Corporation of America Holdings
  • Lonza Group Ltd.
  • Merck KGaA
  • Perkinelmer Inc.
  • Promega Corporation
  • Qiagen NV
  • Quest Diagnostics Incorporated
  • SGS SA
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-1D39DE28BC82

The Toxicity Testing Outsourcing Market was valued at USD 3.97 billion in 2023, expected to reach USD 4.31 billion in 2024, and is projected to grow at a CAGR of 9.03%, to USD 7.28 billion by 2030.

The scope of toxicity testing outsourcing involves contracting external laboratories and service providers to conduct tests assessing the safety and potential harmful effects of chemicals, pharmaceuticals, and other substances. This approach is necessitated by the need for organizations to comply with stringent regulatory requirements, manage costs, and access specialized expertise not available in-house. It finds application across industries such as pharmaceuticals, agrochemicals, biotechnology, and consumer goods, with end-use sectors including pharmaceuticals, cosmetics, food and beverage, and environmental analysis. Market growth is driven by increasing R&D expenditures, technological advancements in testing methodologies, and heightened awareness of chemical safety and environmental impact. Additionally, the move towards animal-free testing and emphasis on predictive toxicity and high-throughput screening open fresh avenues for innovation and ongoing research. Opportunities also arise from expanding markets in emerging economies where regulatory frameworks are becoming more stringent, thereby fueling demand for expert services.

KEY MARKET STATISTICS
Base Year [2023] USD 3.97 billion
Estimated Year [2024] USD 4.31 billion
Forecast Year [2030] USD 7.28 billion
CAGR (%) 9.03%

However, several challenges impede market expansion. These include regulatory hindrances, ethical concerns regarding animal testing, and the high cost of advanced testing technologies. Moreover, varying regional regulations can create complexities for global operations, necessitating adaptable and compliant testing solutions across different jurisdictions. Despite these challenges, investing in technology-driven innovations, such as artificial intelligence and machine learning integration in toxicity prediction models and expanding partnerships and collaborations, can catalyze market growth.

Firms should prioritize innovative development in in vitro, in silico, and alternative testing methods, energy-efficient and cost-effective processes, and use of biotechnology in toxicity forecasting to edge ahead. The market is dynamic, evolving with technological progress and shifting regulatory landscapes, thus emphasizing the need for continuous monitoring and adaptation to identify emerging trends and legislative changes promptly. Engaging in research consortia can further facilitate knowledge sharing and drive industry-standard advancements across networks, ensuring sustained business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Toxicity Testing Outsourcing Market

The Toxicity Testing Outsourcing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising ethical issues about animal testing
    • Increasing focus on drug discovery and personalized medicine
    • Growing number of toxicity databases
  • Market Restraints
    • Lack of standards to establish intricacies of in-vivo conditions
  • Market Opportunities
    • Growing acceptance of toxicity testing services with the evolution of 3D cell culture systems
    • Extensive adoption of toxicology assays attributed to safety time-saving parameters
  • Market Challenges
    • Lack of trained expertise for the toxicity testing procedure

Porter's Five Forces: A Strategic Tool for Navigating the Toxicity Testing Outsourcing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Toxicity Testing Outsourcing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Toxicity Testing Outsourcing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Toxicity Testing Outsourcing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Toxicity Testing Outsourcing Market

A detailed market share analysis in the Toxicity Testing Outsourcing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Toxicity Testing Outsourcing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Toxicity Testing Outsourcing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Toxicity Testing Outsourcing Market

A strategic analysis of the Toxicity Testing Outsourcing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Toxicity Testing Outsourcing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Biognosys AG, BioIVT, LLC, Catalent, Inc., Charles River Laboratories International, Inc., Danaher Corporation, Eagle Analytical, Eurofins Scientific Limited, Evotec SE, Laboratory Corporation of America Holdings, Lonza Group Ltd., Merck KGaA, Perkinelmer Inc., Promega Corporation, Qiagen N.V., Quest Diagnostics Incorporated, SGS S.A., and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Toxicity Testing Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Method, market is studied across In-Vitro toxicity testing and In-Vivo toxicity testing.
  • Based on Practice Type, market is studied across Good Laboratory Practices (GLP) and Non-GLP.
  • Based on End-Use, market is studied across Academic & Research Institutes and Pharmaceutical & Biopharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising ethical issues about animal testing
      • 5.1.1.2. Increasing focus on drug discovery and personalized medicine
      • 5.1.1.3. Growing number of toxicity databases
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of standards to establish intricacies of in-vivo conditions
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing acceptance of toxicity testing services with the evolution of 3D cell culture systems
      • 5.1.3.2. Extensive adoption of toxicology assays attributed to safety time-saving parameters
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of trained expertise for the toxicity testing procedure
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Toxicity Testing Outsourcing Market, by Method

  • 6.1. Introduction
  • 6.2. In-Vitro toxicity testing
  • 6.3. In-Vivo toxicity testing

7. Toxicity Testing Outsourcing Market, by Practice Type

  • 7.1. Introduction
  • 7.2. Good Laboratory Practices (GLP)
  • 7.3. Non-GLP

8. Toxicity Testing Outsourcing Market, by End-Use

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Pharmaceutical & Biopharmaceutical Companies

9. Americas Toxicity Testing Outsourcing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Toxicity Testing Outsourcing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Toxicity Testing Outsourcing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Agilent Technologies, Inc.
  • 3. Bio-Rad Laboratories, Inc.
  • 4. Biognosys AG
  • 5. BioIVT, LLC
  • 6. Catalent, Inc.
  • 7. Charles River Laboratories International, Inc.
  • 8. Danaher Corporation
  • 9. Eagle Analytical
  • 10. Eurofins Scientific Limited
  • 11. Evotec SE
  • 12. Laboratory Corporation of America Holdings
  • 13. Lonza Group Ltd.
  • 14. Merck KGaA
  • 15. Perkinelmer Inc.
  • 16. Promega Corporation
  • 17. Qiagen N.V.
  • 18. Quest Diagnostics Incorporated
  • 19. SGS S.A.
  • 20. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. TOXICITY TESTING OUTSOURCING MARKET RESEARCH PROCESS
  • FIGURE 2. TOXICITY TESTING OUTSOURCING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. TOXICITY TESTING OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. TOXICITY TESTING OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TOXICITY TESTING OUTSOURCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TOXICITY TESTING OUTSOURCING MARKET DYNAMICS
  • TABLE 7. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN-VITRO TOXICITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN-VIVO TOXICITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY GOOD LABORATORY PRACTICES (GLP), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY NON-GLP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. TOXICITY TESTING OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 144. TOXICITY TESTING OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023